CRL

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Peers: IQV LDOS MEDP CVS PFE ILMN BMY LH MRK

| Held by: VTI VOO VB RSP VBR SPY IVV XLV IBB IWR

Index	S&P 500	P/E	-	EPS (ttm)	-1.32	Insider Own	1.12%	Shs Outstand	49.21M	Perf Week	-6.77%
Market Cap	7.52B	Forward P/E	14.16	EPS next Y	10.80	Insider Trans	-0.36%	Shs Float	48.66M	Perf Month	-1.36%
Enterprise Value	10.18B	PEG	-	EPS next Q	2.35	Inst Own	104.16%	Short Float	5.49%	Perf Quarter	0.66%
Income	-69.22M	P/S	1.87	EPS this Y	-1.45%	Inst Trans	-5.14%	Short Ratio	3.03	Perf Half Y	-8.41%
Sales	4.03B	P/B	2.24	EPS next Y	6.15%	ROA	-0.89%	Short Interest	2.67M	Perf YTD	-17.18%
Book/sh	68.14	P/C	41.07	EPS next 5Y	4.45%	ROE	-1.96%	52W High	230.02 -33.53%	Perf Year	-19.54%
Cash/sh	3.72	P/FCF	13.01	EPS past 3/5Y	-70.29% -47.65%	ROIC	-1.13%	52W Low	91.86 66.44%	Perf 3Y	-26.63%
Dividend Est.	-	EV/EBITDA	11.21	Sales past 3/5Y	4.59% 9.09%	Gross Margin	29.96%	Volatility	6.38% 3.34%	Perf 5Y	-25.29%
Dividend TTM	-	EV/Sales	2.53	EPS Y/Y TTM	-115.44%	Oper. Margin	11.86%	ATR (14)	6.25	Perf 10Y	126.20%
Dividend Ex-Date	-	Quick Ratio	1.10	Sales Y/Y TTM	-1.21%	Profit Margin	-1.72%	RSI (14)	41.47	Recom	2.37
Dividend Gr. 3/5Y	- -	Current Ratio	1.36	EPS Q/Q	-38.87%	SMA20	-4.46%	Beta	1.52	Target Price	178.64
Payout	0.00%	Debt/Eq	0.83	Sales Q/Q	0.59%	SMA50	-4.83%	Rel Volume	0.87	Prev Close	159.74
Employees	20100	LT Debt/Eq	0.83	Earnings	Aug 06 BMO	SMA200	-3.44%	Avg Volume	881.46K	Price	152.89
IPO	Jun 23, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	24.69% 4.76%	Trades		Volume	768,761	Change	-4.29%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-09-25	Upgrade	Jefferies	Hold → Buy	$195
Jul-09-25	Upgrade	Citigroup	Neutral → Buy	$200
May-23-25	Upgrade	Redburn Atlantic	Neutral → Buy	$182
May-14-25	Upgrade	TD Cowen	Hold → Buy	$179
May-08-25	Upgrade	Evercore ISI	In-line → Outperform	$170
Mar-21-25	Downgrade	Goldman	Buy → Neutral	$190 → $170
Mar-04-25	Upgrade	Citigroup	Sell → Neutral	$155 → $175
Mar-03-25	Upgrade	Redburn Atlantic	Sell → Neutral	$188
Jan-22-25	Downgrade	William Blair	Outperform → Mkt Perform
Jan-17-25	Downgrade	UBS	Buy → Neutral	$250 → $185
Nov-18-24	Downgrade	CLSA	Hold → Underperform	$164
Nov-07-24	Upgrade	CLSA	Underperform → Hold	$205
Oct-23-24	Initiated	CLSA	Underperform	$167
Oct-14-24	Initiated	Redburn Atlantic	Sell
Oct-07-24	Downgrade	Evercore ISI	Outperform → In-line	$225 → $190
Oct-02-24	Downgrade	BofA Securities	Buy → Neutral	$250 → $215
Oct-01-24	Downgrade	Citigroup	Neutral → Sell	$215 → $175
Aug-08-24	Downgrade	Robert W. Baird	Outperform → Neutral	$239 → $191
Aug-08-24	Downgrade	JP Morgan	Overweight → Neutral	$270 → $205
Jun-28-24	Downgrade	Argus	Buy → Hold

Show Previous Ratings

Sep-12-25 08:44AM	CRL Stock Rises Following New Strategic Oncology Collaborations (Zacks)
Sep-11-25 08:00AM	Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer (Business Wire)
12:35AM	3 Unpopular Stocks That Concern Us (StockStory)
Sep-09-25 12:11PM	Jefferies backs IQVIA and Charles River, cuts ICON on customer losses (Investing.com)
09:35AM	Lululemon downgraded, Dick's Sporting upgraded: Wall Street's top analyst calls (The Fly)
08:00AM	Loading…
Sep-08-25 08:00AM	Charles River Laboratories to Present at Baird and Morgan Stanley Conferences (Business Wire)
Sep-04-25 08:50AM	Is it the Right Time to Add CRL Stock to Your Portfolio Now? (Zacks)
Sep-03-25 08:00AM	Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences (Business Wire)
Sep-02-25 11:24AM	Danaher Gains From Business Strength Amid Persisting Headwinds (Zacks)
Sep-01-25 02:18PM	Podcast: Alternative testing models to shape toxicology with time (Clinical Trials Arena)
10:21AM	Charles River Stock May Benefit From Joining EASYGEN Consortium (Zacks)
Aug-27-25 10:23AM	Charles River Laboratories Stock: Analyst Estimates & Ratings (Barchart)
Aug-26-25 08:00AM	Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing (Business Wire)
Aug-20-25 07:45AM	Factbox-Healthcare firms see growing activist investor involvement in the past year (Reuters)
Aug-18-25 07:32PM	Biotechnology company shrinks Memphis expansion plans by 500+ jobs: Here's what we know (The Commercial Appeal)
01:36AM	Loading…
Aug-13-25 01:36AM	5 Revealing Analyst Questions From Charles River Laboratories's Q2 Earnings Call (StockStory)
Aug-12-25 03:36PM	Cambodian Monkey, Destined for Research, Dies During Transport to Canada (GlobeNewswire)
03:13AM	CRL Q2 Deep Dive: Flat Sales and Margin Pressures Offset by Demand Stabilization and Raised Outlook (StockStory)
Aug-11-25 09:15AM	Interpreting Charles River (CRL) International Revenue Trends (Zacks)
Aug-06-25 10:18PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research) -10.25%
09:30AM	Charles River (CRL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
09:24AM	CRL Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 View (Zacks)
08:56AM	Charles River Laboratories (NYSE:CRL) Delivers Impressive Q2 (StockStory)
08:15AM	Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates (Zacks)
07:27AM	Charles River: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Charles River Laboratories Announces Second-Quarter 2025 Results (Business Wire)
Aug-05-25 08:45AM	Organon (OGN) Beats Q2 Earnings and Revenue Estimates (Zacks)
Aug-04-25 11:26PM	Charles River Laboratories (CRL) Reports Earnings Tomorrow: What To Expect (StockStory)
Jul-31-25 10:00AM	Analysts Estimate AMN Healthcare Services (AMN) to Report a Decline in Earnings: What to Look Out for (Zacks)
08:00AM	Charles River and BioTech Social Inc. Pursue Crowdfunding Partnership (Business Wire)
10:00AM	Loading…
Jul-30-25 10:00AM	Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
08:20AM	Charles River Q2 Earnings Preview: What's in Store for the Stock? (Zacks)
05:26AM	Pharma Formulation Development Outsourcing Forecast Report 2025-2033 Featuring SGS, Intertek, Recipharm, Lonza, Charles River Laboratories, Eurofins Scientific, Labcorp, Thermo Fisher Scientific (GlobeNewswire)
Jul-24-25 10:53AM	Stock Market Today: S&P 500, Nasdaq Touch Records; Rail Merger Talks; West Pharma in Focus (TheStreet) +5.45%
10:53AM	Stock Market Today: Investors Await After-Hours Results from Intel, Newmont, Deckers Brands (TheStreet)
Jul-22-25 12:10PM	Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report? (Zacks) +9.06%
11:56AM	Why Are Charles River Laboratories (CRL) Shares Soaring Today (StockStory)
08:00AM	Charles River Joins Ellys Team to Drive Rare Disease Gene Therapy Development (Business Wire)
Jul-18-25 08:09AM	Here's What to Expect From Charles River Laboratories' Next Earnings Report (Barchart)
Jul-16-25 08:19AM	Is it Prudent to Retain Charles River Stock in Your Portfolio Now? (Zacks)
Jul-15-25 01:56PM	Simulations Plus Sees Weaker Demand Persist, Outlook Softens (Benzinga)
09:51AM	Charles River Laboratories International (CRL) is Expected to Gain as Industry Growth Resumes (Insider Monkey)
08:00AM	Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call (Business Wire)
Jul-08-25 08:11AM	Myrtelle Launches Manufacturing of First-in-Class Gene Therapy for Canavan Disease in Strategic Alliance with Charles River and Viralgen (PR Newswire)
Jul-04-25 01:31AM	5 Revealing Analyst Questions From Charles River Laboratories's Q1 Earnings Call (StockStory)
Jun-25-25 11:34AM	Is Charles River Laboratories Stock Underperforming the S&P 500? (Barchart)
Jun-18-25 12:02AM	3 Reasons to Sell CRL and 1 Stock to Buy Instead (StockStory)
Jun-16-25 08:00AM	Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment (Business Wire)
Jun-11-25 05:28AM	CRL Q1 Earnings Call: Regulatory Changes and Market Stabilization Shape Outlook (StockStory)
Jun-10-25 03:48PM	Megacap stocks aren't all up in 2025. But this chart shows they've trounced the S&P 500's smallest equities. (MarketWatch)
Jun-06-25 11:31AM	Why Is Charles River (CRL) Down 0.1% Since Last Earnings Report? (Zacks)
Jun-02-25 08:12AM	Charles River Stock May Gain From Extended CHDI Research Deal on HD (Zacks)
08:00AM	Charles River Laboratories to Present at William Blair and Jefferies Conferences (Business Wire)
May-30-25 12:46AM	Charles River Laboratories International, Inc. (CRL): A Bull Case Theory (Insider Monkey)
May-28-25 08:00AM	Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntingtons Disease Research (Business Wire)
May-24-25 03:55AM	Redburn Upgrades Charles River Laboratories (CRL) to Buy, Cuts PT (Insider Monkey)
May-20-25 08:53AM	Should You Continue to Hold Charles River Stock in Your Portfolio? (Zacks)
May-19-25 11:34PM	Drug Development Inputs & Services Stocks Q1 Results: Benchmarking Charles River Laboratories (NYSE:CRL) (StockStory)
May-13-25 09:16AM	Understanding Charles River (CRL) Reliance on International Revenue (Zacks)
08:00AM	Charles River Laboratories to Present at Bank of America Health Care Conference (Business Wire)
May-09-25 07:00AM	Eli Lilly extends Purdue alliance; EMA investigates Valneva shot (BioPharma Dive)
May-08-25 03:18AM	Charles River Laboratories International Inc (CRL) Q1 2025 Earnings Call Highlights: Navigating ... (GuruFocus.com)
May-07-25 09:34PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research) +18.68%
05:19PM	S&P 500 Gains & Losses Today: Stocks Gain in Volatile Session as Markets React to Fed Meeting, Trump Trade Comments (Investopedia)
04:22PM	Charles River to initiate a review amid Elliott stake - Is a sale next? (Investing.com)
02:47PM	Charles river raises 2025 guidance with focus on NAMs and cost optimization (Seeking Alpha)
02:46PM	Charles River Laboratories International, Inc. (CRL) Q1 2025 Earnings Call Transcript (Seeking Alpha)
12:17PM	Charles River Stock Is Having Its Best Day in 13 Years. A Board Shake-Up and Business Review Will Help. (Barrons.com)
11:51AM	Top Stock Moves Now: Charles River Labs, Disney, Supermicro, and More (Investopedia)
10:23AM	Charles River Labs Stock Soars as Firm Shakes Up Board, Launches Review (Investopedia)
09:51AM	Charles River announces strategic review including 'examination of various alternatives' (Seeking Alpha)
09:35AM	CRL Q1 Earnings & Revenues Beat Estimates, Stock Rises, '25 View Up (Zacks)
09:30AM	Compared to Estimates, Charles River (CRL) Q1 Earnings: A Look at Key Metrics (Zacks)
09:04AM	Charles River surges after Q1 beat, guidance raise (Seeking Alpha)
08:15AM	Charles River Laboratories (CRL) Beats Q1 Earnings and Revenue Estimates (Zacks)
07:13AM	Charles River: Q1 Earnings Snapshot (Associated Press Finance)
07:01AM	Charles River Laboratories Announces First-Quarter 2025 Results (Business Wire)
07:00AM	Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value (Business Wire)
06:08AM	Charles River to add new directors, review business in agreement with Elliott (Reuters)
May-05-25 12:50PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research)
May-01-25 10:01AM	Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
09:15AM	ClearBridge All Cap Growth Portfolios Q1 2025 Commentary (Seeking Alpha)
Apr-30-25 07:39PM	Charles River Laboratories International, Inc. (CRL): Among the Worst Performing Stocks in S&P 500 So Far in 2025 (Insider Monkey)
11:45AM	The Davenport Insider Buying Fund Q1 2025 Commentary (Seeking Alpha)
10:01AM	Analysts Estimate Charles River Laboratories (CRL) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-29-25 08:00AM	Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort (Business Wire)
Apr-28-25 09:12AM	Here's How Charles River is Placed Just Ahead of Q1 Earnings (Zacks)
Apr-22-25 10:01AM	Upslope Capital Management Sold Charles River (CRL) Due to Thesis Break (Insider Monkey)
08:00AM	Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development (Business Wire)
Apr-17-25 11:01PM	Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025 (Insider Monkey)
Apr-16-25 07:55AM	The 2 Worst Performing S&P 500 Stocks YTD: Buy, Sell, or Avoid? (MarketBeat)
Apr-15-25 04:30PM	Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call (Business Wire)
10:35AM	Upslope Capital's Q1 2025 Investor Letter (Seeking Alpha)
08:26AM	Strength Seen in Charles River (CRL): Can Its 6.9% Jump Turn into More Strength? (Zacks)
Apr-12-25 08:15AM	Charles River Gets Hit By The FDA, Too Early To Bet On A Comeback (Seeking Alpha)
07:50AM	What Moved Markets This Week (Seeking Alpha)
Apr-11-25 02:36PM	Charles River Faces Significant Regulatory And Macro Pressures (Seeking Alpha)
05:46AM	Why Charles River Laboratories International, Inc. (CRL) Went Down On Thursday? (Insider Monkey)
Apr-10-25 08:43PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research) -28.13%
12:10PM	Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report? (Zacks)

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Joseph LaPlume	Officer	Aug 22 '25	Proposed Sale	152.50	400	61,000		Aug 22 01:37 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Aug 18 '25	Sale	157.60	800	126,080	24,116	Aug 20 04:45 PM
WALLMAN RICHARD F	Former Director	Aug 18 '25	Proposed Sale	152.00	22,500	3,420,000		Aug 18 05:16 PM
Joseph LaPlume	Officer	Aug 18 '25	Proposed Sale	157.00	800	125,600		Aug 18 01:27 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Aug 07 '25	Sale	150.04	400	60,016	24,916	Aug 08 04:18 PM
Joseph LaPlume	Officer	Aug 07 '25	Proposed Sale	150.00	400	60,000		Aug 07 02:57 PM
WALLMAN RICHARD F	Former Director	Jul 21 '25	Proposed Sale	150.00	8,500	1,275,000		Jul 21 04:21 PM
WALLMAN RICHARD F	Former Director	Jun 23 '25	Proposed Sale	137.50	4,000	550,000		Jun 25 04:34 PM
MASSARO GEORGE	Director	May 15 '25	Sale	137.57	140	19,260	5,575	May 16 04:29 PM
MASSARO GEORGE	Director	May 14 '25	Sale	140.73	140	19,703	5,715	May 15 04:41 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	May 13 '25	Sale	145.41	500	72,705	19,513	May 15 04:38 PM
MASSARO GEORGE	Director	May 14 '25	Proposed Sale	140.73	280	39,405		May 14 04:05 PM
Joseph LaPlume	Officer	May 13 '25	Proposed Sale	144.32	500	72,160		May 13 03:33 PM
FOSTER JAMES C	Chairman, President and CEO	Feb 20 '25	Buy	165.01	6,075	1,002,436	183,639	Feb 21 04:41 PM
Girshick Birgit	Corporate Executive VP & COO	Feb 20 '25	Buy	164.63	1,514	249,250	55,058	Feb 21 04:38 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Feb 20 '25	Sale	162.50	4,400	715,000	20,013	Feb 21 04:36 PM
Joseph LaPlume	Officer	Feb 20 '25	Proposed Sale	165.00	4,400	726,000		Feb 20 12:36 PM
WALLMAN RICHARD F	Director	Nov 07 '24	Sale	216.12	6,621	1,430,918	12,386	Nov 12 04:38 PM
WALLMAN RICHARD F	Director	Nov 07 '24	Sale	216.50	1,000	216,500	0	Nov 12 04:38 PM
WALLMAN RICHARD F	Director	Nov 07 '24	Proposed Sale	216.01	12,161	2,626,923		Nov 07 04:23 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Charles River Laboratories International Inc

Upgrade your FINVIZ experience